The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Gut bacterial translocation is associated with microinflammation in end‐stage renal disease patients
Abstract
Aim: To investigate whether gut bacteria translocation occurs in end‐stage renal disease patients and contributes to microinflammation in end‐stage renal disease (ESRD). Methods: The subjects were divided into two groups: nondialysed ESRD patients (n = 30) and healthy controls (n = 10). Blood samples from all participants were subjected to bacterial 16S ribosomal DNA amplification and DNA pyrosequencing to determine the presence of bacteria, and the alteration of gut microbiomes were examined with the same methods. High‐sensitive C‐reactive protein and interleukin‐6 were detected. Plasma D‐lactate was tested for gut permeability. Results: Bacterial DNAs were detected in the blood of 20% (6/30) of the ESRD patients. All the observed genera in blood (Klebsiella spp, Proteus spp, Escherichia spp, Enterobacter spp, and Pseudomonas spp) were overgrown in the guts of the ESRD patients. Plasma D‐lactate, High‐sensitive C‐reactive protein, and interleukin‐6 levels were significantly higher in patients with bacterial DNA than those without. The control group showed the same results as that of patients without bacterial DNA. Conclusion: Bacterial translocation occurs in ESRD patients and is associated with microinflammation in end stage renal disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast to Lactobacillus, the population of Enterobacteriaceae of the Proteobacteria phylum is expanded in CKD101,105.”
From The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease (2018) · cites this paper as [105]
Citations
Cites
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401
Inflammation enhances cardiovascular risk and mortality in hemodialysis patients
Zimmermann, J., Herrlinger, S., Pruy, A., Metzger, T., & Wanner, C. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00273.x · Cited by 1,531
Bacterial translocation (BT) in cirrhosis†
Wiest, R., & Garcia‐Tsao, G. (2005) · Hepatology · doi:10.1002/hep.20632 · Cited by 677
The Macaque Gut Microbiome in Health, Lentiviral Infection, and Chronic Enterocolitis
McKenna, P. M., Hoffmann, C., Minkah, N. K., Aye, P. P., Lackner, A. A., Liu, Z. Z., Lozupone, C., Hamady, M., Knight, R. D., & Bushman, F. D. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.0040020 · Cited by 445
Macfie, J., OBoyle, C., Mitchell, C. J., Buckley, P. M., Johnstone, D. J., & Sudworth, P. (1999) · Gut · doi:10.1136/gut.45.2.223 · Cited by 414
Steffen, E. K., Berg, R. D., & Deitch, E. A. (1988) · Journal of Infectious Diseases · doi:10.1093/infdis/157.5.1032 · Cited by 234
Serum D(−)-lactate levels as an aid to diagnosing acute intestinal ischemia
Murray, M. J., Gonze, M. D., Nowak, L. R., & Cobb, C. F. (1994) · The American Journal of Surgery · doi:10.1016/0002-9610(94)90101-5 · Cited by 224
Bacterial translocation in the gut
Wiest, R., & Rath, H. C. (2003) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/s1521-6918(03)00024-6 · Cited by 206
Apoptosis as a proinflammatory event: What can we learn from bacteria-induced cell death?
Zychlinsky, A., & Sansonetti, P. J. (1997) · Trends in Microbiology · doi:10.1016/s0966-842x(97)01044-5 · Cited by 184
Cited by
Sorted by citations
Items 101–200 of 209
Vaziri, N. D. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3287-z · Cited by 30
The role of chronic kidney disease-associated dysbiosis in cardiovascular disease
Bryniarski, M. A., Hamarneh, F., & Yacoub, R. (2019) · Experimental Biology and Medicine · doi:10.1177/1535370219826526 · Cited by 31
Kanmani, S., Son, T., Kim, K., & Koo, B. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104583 · Cited by 31
Strongyloides stercoralis infection induces gut dysbiosis in chronic kidney disease patients
Hai, N. T., Hongsrichan, N., Intuyod, K., Pinlaor, P., Yingklang, M., Chaidee, A., Pongking, T., Anutrakulchai, S., Cha’on, U., & Pinlaor, S. (2022) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0010302 · Cited by 29
Gastrin, via activation of PPARα, protects the kidney against hypertensive injury
Gu, D., Fang, D., Zhang, M., Guo, J., Ren, H., Li, X., Zhang, Z., Yang, D., Zou, X., Liu, Y., et al. (2021) · Clinical Science · doi:10.1042/cs20201340 · Cited by 28
Bin-Jumah, M. N., Gilani, S. J., Hosawi, S. B. I., Al-Abbasi, F. A., Zeyadi, M., Imam, S. S., Alshehri, S., Ghoneim, M. M., Nadeem, M. S., & Kazmi, I. A. (2021) · Nutrients · doi:10.3390/nu13103453 · Cited by 28
“This process is directly linked with microbial and microbial metabolite translocation [64,65].”
BackgroundThe cross-talk between the kidney and the gut: implications for chronic kidney disease
de Andrade, L. S., Ramos, C. I., & Cuppari, L. (2017) · Nutrire · doi:10.1186/s41110-017-0054-x · Cited by 28
“There is indirect evidence linking CKD with damage to the barrier function of the intestinal mucosa (increased intestinal permeability), such as the presence of endotoxemia in the absence of infection [7, 61, 62], bacterial translocation [8], and detection of intestinal bacteria DNA in the blood [63].”
BackgroundGut–Kidney Axis Investigations in Animal Models of Chronic Kidney Disease
Bartochowski, P., Gayrard, N., Bornes, S., Druart, C., Argilés, À., Cordaillat‐Simmons, M., & Duranton, F. (2022) · Toxins · doi:10.3390/toxins14090626 · Cited by 29
Melekoğlu, E., & Samur, G. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1996331 · Cited by 33
Wei, M., Wang, Z., Liu, H., Jiang, H., Wang, M., Liang, S., Shi, K., & Feng, J. (2014) · Nephrology · doi:10.1111/nep.12272 · Cited by 26
“Our previous study in which we sequenced bacterial 16SrRNA also demonstrated the occurrence of intestinal BT in uraemic rats and human patients.(11,18) Several factors contribute to the development of BT in uraemia.”
BackgroundSelf-citationMiric, D. J., Kisić, B., Stolic, R. V., Mirić, B., Mitić, R., & Janićijević-Hudomal, S. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/245253 · Cited by 23
Beta-glucans in advanced CKD: role in endotoxaemia and inflammation
Wong, J., Zhang, Y., Swift, O., Finkelman, M., Patidar, A., Ramanarayanan, S., Vilar, E., & Farrington, K. (2020) · BMC Nephrology · doi:10.1186/s12882-020-01779-9 · Cited by 20
Microbiota analysis in the hemodialysis population - Focusing on Enterobacteriaceae
Wu, H., Lin, Y.-T., Tsai, W., Chiu, Y., Ko, M., Yang, J., Pai, M., Hsu, H.-S., Hsu, S., Peng, Y., et al. (2022) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2022.12.001 · Cited by 19
The Role and Impact of Gut Microbiota in Cardiovascular Disease
Kitai, T., & Tang, W. H. W. (2017) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2017.04.007 · Cited by 18
“Plasma inflammatory markers, such as high-sensitive C-reactive protein and interleukin-6 levels, were higher in patients with bacterial DNA in the blood than in those without.(8) In a recent study, a”
BackgroundImpacto de la microbiota intestinal en la enfermedad cardiovascular
Kitai, T., & Tang, W. H. W. (2017) · Revista Española de Cardiología · doi:10.1016/j.recesp.2017.04.003 · Cited by 20
Hypertension in Chronic Kidney Disease: Novel Insights
Duni, Α., Dounousi, E. C., Pavlakou, P., Eleftheriadis, T., & Liakopoulos, V. (2019) · Current Hypertension Reviews · doi:10.2174/1573402115666190415153554 · Cited by 17
The Role of the Gut Microbiota in Complications among Hemodialysis Patients
Du, J., Zhao, X., Ding, X., Han, Q., Duan, Y., Ren, Q., Wang, H., Song, C., Wang, X., Zhang, D., et al. (2024) · Microorganisms · doi:10.3390/microorganisms12091878 · Cited by 16
“These findings suggest that bacterial translocation occurs in patients with ESRD and is associated with microinflammation [54].”
BackgroundLin, W., Jiang, C., Yu, H., Wang, L., Li, J., Liu, X., Wang, L., & Yang, H. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153561 · Cited by 16
Gut Dysbiosis and Probiotic Therapy in Chronic Kidney Disease: A Comprehensive Review
Ribeiro, F. P. B., Freire, M. O. D. L., Coutinho, D. D. O., Cirilo, M. A. D. S., & Alves, J. L. D. B. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10427-9 · Cited by 17
“…from the intestinal tract in blood samples from end-stage CKD patients through pyrosequencing of bacterial DNA, including Klebsiella spp., Proteus spp., Escherichia spp., Enterobacter spp., and Pseudomonas spp., which were associated with the state of microinflammation in these patients [51].”
Xiao, Y., Zhao, J., Zhang, H., Zhai, Q., & Chen, W. (2021) · Foods · doi:10.3390/foods10102284 · Cited by 17
“showed increased levels in the gut of patients with multiple sclerosis [51] and end-stage renal disease [52], represented a higher positive rate in the ileum of Crohn’s disease patients compared with the healthy control group [53], and reflected a positive correlation with pro-inflammatory cytokine IL-6 [54].”
BackgroundCould Physical Exercise Help Modulate the Gut Microbiota in Chronic Kidney Disease?
Esgalhado, M., Borges, N. A., & Mafra, D. (2016) · Future Microbiology · doi:10.2217/fmb.16.12 · Cited by 16
Kuskunov, T., Tilkiyan, E. E., Doykov, D. I., Boyanov, K., Bivolarska, A. V., & Hristov, B. K. (2023) · Medicina · doi:10.3390/medicina59081383 · Cited by 14
“A significant association between dysbiotic gut microbiota and low-grade systemic inflammation in end-stage CKD patients has been demonstrated [42].”
BackgroundSun, L., Liu, H., Jiang, H., Wei, M., Liang, S., Wang, M., Shi, K., & He, Q. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3950-z · Cited by 14
Self-citationIn vitro effect of uremic serum on barrier function and inflammation in human colonocytes
de Andrade, L. S., Dalboni, M. A., de Carvalho, J. T. G., Grabulosa, C. C., Pereira, N. B. F., Aoike, D. T., & Cuppari, L. (2018) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-3949 · Cited by 14
Gut Dysbiosis in Experimental Kidney Disease: A Meta-Analysis of Rodent Repository Data
Randall, D. W., Kieswich, J. E., Hoyles, L., McCafferty, K., Curtis, M. A., & Yaqoob, M. M. (2023) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000000000071 · Cited by 14
Lazarević, V., Teta, D., Pruijm, M. T., Stoermann, C., Marangon, N., Mareschal, J., Solano, R., Wurzner-Ghajarzadeh, A., Gaïa, N., Cani, P. D., et al. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1298432 · Cited by 14
Chang, S., Huang, N., & Hu, H. (2016) · Medicine · doi:10.1097/md.0000000000004881 · Cited by 13
“Wang et al([16]) proposed that immune defense system suppression occurs in ESRD and that the mechanisms of BT are gastrointestinal microflora alteration, gut mucosal barrier disruption, and host defense impairment.”
BackgroundProbiotics, gut microbiome, and cardiovascular diseases: An update
Dosh, L., Ghazi, M., Haddad, K., Masri, J. E., Hawi, J. S., Leone, A., Basset, C. A., Geagea, A. G., Jurjus, R. A., & Jurjus, A. R. (2024) · Transplant Immunology · doi:10.1016/j.trim.2024.102000 · Cited by 11
Toll-like receptor 4 mutation mitigates gut microbiota-mediated hypertensive kidney injury
Majumder, S., Pushpakumar, S. B., Almarshood, H., Ouseph, R., Gondim, D. D., Jala, V. R., & Sen, U. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107303 · Cited by 11
“Also, it has been reported that disrupted gut barrier function causes bacterial translocation from the gut to the kidney [23,64,65].”
BackgroundCOLONIC MICROBIOTA AND CHRONIC KIDNEY DISEASE. MESSAGE ONE
Lukichev, B. G., Rumyantsev, A. S., & Акименко, В. Б. (2018) · Nephrology (Saint-Petersburg) · doi:10.24884/1561-6274-2018-22-4-57-73 · Cited by 11
Chen, T.-H., Cheng, C., Huang, C., Ho, Y.-H., & Lin, J.-C. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02805-22 · Cited by 11
“In brief, increases in the opportunistic pathogens, including Enterococcus, Enterobacteriaceae, and Klebsiella genera were identified under the hypertensive condition (29, 30).”
BackgroundWu, B., Jiang, H., He, Q., Wang, M., Xue, J., Liu, H., Shi, K., Wei, M., Liang, S., & Zhang, L. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000452453 · Cited by 10
Self-citationMartinez, L., Perla, M., Tabbara, M., Duque, J. C., Rojas, M. G., Falcon, N. S., Pereira‐Simon, S., Salman, L. H., & Vázquez-Padrón, R. I. (2022) · Kidney360 · doi:10.34067/kid.0006022021 · Cited by 10
“These include central venous catheters and dialysis itself (2, 9, 10); underlying comorbidities and autonomic imbalance (11, 12); increased gut permeability and dysbiosis (13-15); and symptomatic or subclinical infections of various etiologies (16, 17).”
BackgroundPotential biomarkers of acute myocardial infarction based on the composition of the blood microbiome
Chen, R., Ye, Y., Ding, Y., Wan, Z., Ye, X., & Liu, J. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.117843 · Cited by 9
Serum Sphingosine-1-phosphate level and peritonitis in peritoneal dialysis patients
Bai, Q., Guo, H., Su, C., Han, Q., Wang, T., & Tang, W. (2020) · Renal Failure · doi:10.1080/0886022x.2020.1805763 · Cited by 9
Rootjes, P. A., Nubé, M. J., van Zuijdewijn, C. L. M. D. R., Wijngaarden, G., & Grooteman, M. P. C. (2021) · BMC Nephrology · doi:10.1186/s12882-021-02331-z · Cited by 9
The possible role of a bacterial aspartate β-decarboxylase in the biosynthesis of alamandine
Jha, S., Speth, R. C., & Macheroux, P. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110038 · Cited by 9
“Loss of intestinal epithelium integrity in ESRD leads to GBT, causing chronic inflammation [37,42].”
BackgroundDietary phosphate disturbs of gut microbiome in mice
Oda, N., Sugihara, K., Uebanso, T., Ohminami, H., Ohnishi, K., Masuda, M., Yamanaka‐Okumura, H., & Taketani, Y. (2023) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.23-9 · Cited by 12
IMMUNOLOGICAL ASPECTS OF ESSENTIAL HYPERTENSION
Timasheva, Y. (2019) · Medical Immunology (Russia) · doi:10.15789/1563-0625-2019-3-407-418 · Cited by 8
Bacterial metabolites and cardiovascular risk in children with chronic kidney disease
Schlender, J., Behrens, F., McParland, V. J., Müller, D. N., Wilck, N., Bartolomaeus, H., & Holle, J. B. (2021) · Molecular and Cellular Pediatrics · doi:10.1186/s40348-021-00126-8 · Cited by 10
“Further evidence for the leaky gut phenotype in CKD includes the detection of bacteria DNA fragments in the intestinal wall [26, 183, 184], reduced transepithelial electrical resistance in vitro following incubation with a pre-dialysis plasma of ESKD patients which can be rescued with post-dialysis plasma [185], and d…”
BackgroundSwift, O., Vilar, E., & Farrington, K. (2019) · Seminars in Dialysis · doi:10.1111/sdi.12810 · Cited by 8
Intestinal dialysis for conservative management of Uremia
Puri, I., Shirazi, N. M., Yap, E., & Saggi, S. J. (2019) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000571 · Cited by 8
Risk Factors for Renal Impairment in Adult Patients With Short Bowel Syndrome
Wang, P., Yang, J., Zhang, Y., Zhang, L., Gao, X., & Wang, X. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2020.618758 · Cited by 8
“One paper also suggested that the overgrown bacteria translocated from the gut to the blood, where they contributed to the development of CKD (16).”
BackgroundInfluentialSun, X., Sun, W., Huang, Y., & Chen, J. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/7940684 · Cited by 7
In vivo evaluation of an innovative synbiotics on stage IIIb-IV chronic kidney disease patients
Vacca, M., Celano, G., Calabrese, F. M., Rocchetti, M. T., Iacobellis, I., Serale, N., Calasso, M. P., Gesualdo, L., & Angelis, M. D. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1215836 · Cited by 8
“A scenario that was confirmed by previous evidence enlightening how some Proteobacteria species entered the blood stream in end-stage renal disease (ESRD) patients (38).”
ResultYan, P., Luo, S., Guo, L., Wang, X., Ren, X., Lv, J., Chen, Y., Lin, X., Chen, J., & Wang, R. (2023) · Microorganisms · doi:10.3390/microorganisms11112747 · Cited by 7
“Feiqian et al. reported an overgrowth of Klebsiella , Proteus , Escherichia , Enterobacter , and Pseudomonas at the genus level in non-dialyzed ESRD patients ( n = 30) when contrasted with healthy controls ( n = 10), with unadjusted p < 0.05 being considered statistically significant [22].”
BackgroundInfluentialCho, N., Nam, B. D., Park, S., Kim, H., Noh, H., Jeon, J. S., Han, D. C., Lee, E. Y., Gil, H., & Kwon, S. H. (2021) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.21.090 · Cited by 7
Arterial hypertension: The role of gut microbiota
Barantsevich, N. E., Конради, А. О., & Barantsevich, E. P. (2020) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2019-25-5-460-466 · Cited by 7
Rahman, W. K., Al-Diwaniyah Health Office, M. O. H. A. E., Rabeea, I. S., & Meizel, M. M. (2023) · Journal of Medicine and Life · doi:10.25122/jml-2023-0128 · Cited by 6
Tsay, T.-B., Yang, M.-C., Sun, J., Chen, P.-H., Lin, Y., Shih, M.-H., & Chen, L.-W. (2016) · Formosan Journal of Surgery · doi:10.1016/j.fjs.2016.04.007 · Cited by 6
Koppe, L., Beddhu, S., Chauveau, P., Kovesdy, C. P., Mafra, D., Joshi, S., Kalantar‐Zadeh, K., & Fouque, D. P. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab033 · Cited by 6
Inflammation and Chronic Kidney Disease: Current Approaches and Recent Advances
Mihai, S., Codrici, E., Popescu, I. D., Enciu, A., Necula, L. G., Anton, G., & Tănase, C. (2018) · InTech eBooks · doi:10.5772/intechopen.72716 · Cited by 6
Cong, F., Bao, H., Wang, X., Tang, Y., Bao, Y., Poulton, J. S., Liu, X., Wong, A. C.-N., Ji, X. S., & Deng, W. (2025) · The EMBO Journal · doi:10.1038/s44318-025-00458-5 · Cited by 5
“…patients, alternations in the mucus layer and increased colon permeability have been reported, (Vaziri et al, 2012; McIntyre et al, 2011) and bacterial translocation was detected in 20% of end-stage renal disease patients though blood tests for bacteria-derived DNA fragment (Wang et al, 2012).”
Pyatchenkov, M. O., Rumyantsev, A. S., Sherbakov, E. V., & Markov, A. G. (2022) · Nephrology (Saint-Petersburg) · doi:10.36485/1561-6274-2022-26-2-46-64 · Cited by 5
Dirweesh, A. M., Amodu, A., Khan, M. A., Zijoo, R., Ambreen, B., Ibrahim, M., Ijaz, M., Nawwar, A., Genena, K., Tahir, M. W., et al. (2017) · Gastroenterology Research · doi:10.14740/gr784w · Cited by 5
“Wang et al proposed that the immunosuppression status in patients with ESRD together with the alteration in colonic microflora and mucosal barrier disruption are the main mechanisms for gut bacterial translocation [22].”
BackgroundGut microbiota and cardiac arrhythmia: a pharmacokinetic scope
Nabeh, O. A. (2022) · The Egyptian Heart Journal · doi:10.1186/s43044-022-00325-2 · Cited by 4
“This supports the speculation that the translocated gut bacteria contribute to the pathology of CKD [43].”
BackgroundInfluentialPezzuoli, C., Biagini, G., & Magistroni, R. (2024) · Nutrients · doi:10.3390/nu16162676 · Cited by 5
“Healthy control subjects had a significantly higher presence of Actinobacteria, whereas ADPKD patients had increased levels of potentially harmful Enterobacteriaceae, as previously seen in chronic kidney disease patients [88,89].”
BackgroundPokryshko, O., & Khomenko, V. (2023) · Bulletin Of Medical And Biological Research · doi:10.61751/bmbr.2706-6290.2023.2.15 · Cited by 4
Bi, X., Liu, Y., Lu, Y., Ling, L., Lü, J., Hu, C., & Ding, W. Q. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1270690 · Cited by 4
“Thus, gut microbiota disorders may probably be involved in the consistent inflammation detected in PEW (21).”
BackgroundZadora, W., Jacobs, E., Lauriola, M., Dejongh, S., Verstockt, B., Farré, R., & Meijers, B. K. I. (2026) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfag082 · Cited by 4
de Carvalho, T. B., Barbosa, J. B., de Carvalho, N. M., Komora, N., Carvalho, F., Madureira, A. R., & Teixeira, P. C. M. (2025) · Food Research International · doi:10.1016/j.foodres.2025.116287 · Cited by 3
Human microbiota alterations — emerging predictors of renal diseases and kidney-specific aging
Pan, M., Zhang, M., Rong, X., & Zhao, C. (2023) · Aging Pathobiology and Therapeutics · doi:10.31491/apt.2023.03.105 · Cited by 3
Gut permeability, circulating bacterial fragments and measures of congestion in peritoneal dialysis
Li, C., Ng, J. K., Chan, G. C., Fung, W. W., Lai, K., Poon, P. Y., Luk, C. C., Chow, K., & Szeto, C. (2024) · Clinical Kidney Journal · doi:10.1093/ckj/sfae056 · Cited by 3
“This result is consistent with previous reports on elevated plasma endotoxin levels in patients with diabetes or insulin resistance [32 ], which are believed to result from alterations in gut transit time and bacterial overgrowth in the small intestine [33 , 34 ].”
ResultRootjes, P. A., Grooteman, M. P. C., Budding, A. E., Bontkes, H. J., Wijngaarden, G., Nubé, M. J., & van Zuijdewijn, C. L. M. D. R. (2024) · Kidney International Reports · doi:10.1016/j.ekir.2024.09.025 · Cited by 3
elaaty, T. A., Ismail, A. A., Meheissen, M. A., & Essawy, N. R. E. (2019) · Clinical Diabetology · doi:10.5603/dk.2019.0014 · Cited by 3
“While some data on translocation markers and their relationship to chronic inflammation is available for chronic kidney disease patients [29], very little is known about this relationship in T2DM patients.”
BackgroundThe state of the intestinal microbial-tissue complex in patients with chronic kidney disease
Pyatchenkov, M. O., Петровна, С. С., Sherbakov, E. V., & Vlasov, A. A. (2023) · Bulletin of the Russian Military Medical Academy · doi:10.17816/brmma124822 · Cited by 3
Bossola, M. (2015) · Seminars in Dialysis · doi:10.1111/sdi.12442 · Cited by 3
Prebavna cev in srčno-žilne bolezni – ali imajo kaj skupnega?
Skok, P., & Skok, K. (2020) · Slovenian Medical Journal · doi:10.6016/zdravvestn.2989 · Cited by 2
Kadariswantiningsih, I. N., Thaha, M., Nugroho, C. W., & Empitu, M. A. (2019) · Bali Medical Journal · doi:10.15562/bmj.v8i1.1285 · Cited by 3
Influence of dietary fiber on chronic kidney disease： Base on the gut-kidney axis theory.
Xie, X., Dai, S., Dai, Y., & Ning, J. (2020) · PubMed · doi:10.11817/j.issn.1672-7347.2020.180758 · Cited by 3
Microbiota-based therapies for chronic kidney disease
Putri, D. N. A., & Nababan, C. C. M. (2019) · Intisari Sains Medis · doi:10.15562/ism.v10i1.239 · Cited by 2
Rahman, W. K., Rabeea, I. S., & Meizel, M. M. (2024) · Medical Journal of Babylon · doi:10.4103/mjbl.mjbl_676_23 · Cited by 2
Obesity, Cardiometabolic Risk, and Chronic Kidney Disease
Snyder, S., & Gangeri, N. (2015) · Springer eBooks · doi:10.1007/978-3-319-19821-7_14 · Cited by 2
Shifris, І. (2020) · Ukrainian Journal of Nephrology and Dialysis · doi:10.31450/ukrjnd.2(66).2020.04 · Cited by 2
Han, M., Yu, H., Yang, K., Liu, P., Yan, H., Yang, Z., & Yang, H. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/2097569 · Cited by 2
“Studies have shown that bacterial DNA fragments from the gut can be detected in the serum of CKD patients whether they are nondialysis patients or dialysis patients [8, 10].”
BackgroundThe gut microbiome in chronic kidney disease
Merino-Ribas, A., Costa, C. F. F. A., Azevedo, M. J., Alencastre, I. S., Pestana, M., Araújo, R., & Sampaio‐Maia, B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91313-3.00012-x · Cited by 2
First report of Enterobacter cloacae causing soft rot disease on potato in Iraq
DHAHIR, H., & Ahmed, F. A. (2023) · Journal of Kerbala for Agricultural Sciences · doi:10.59658/jkas.v10i3.1120 · Cited by 2
Intestinal microbiota – a possible contributor to cardiovascular diseases?
Iorga, R., Bratu, O. G., Bacalbașa, N., Găman, M., & Diaconu, C. (2020) · Journal of Mind and Medical Sciences · doi:10.22543/7674.72.p168172 · Cited by 2
Anandh, U., & Saxena, A. (2024) · Journal of Renal Nutrition and Metabolism · doi:10.4103/jrnm.jrnm_1_23 · Cited by 1
Artificial intelligence-driven multi-omics analysis of gut-kidney axis in chronic kidney disease
Rajalakshmi, S. G., Sreehari, E., & Viswanathan, P. (2026) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2026.01.015 · Cited by 1
Microbiota and Kidney: Is There a Correlation?
Merra, G., Capacci, A., Cenname, G., Esposito, E., Dri, M., Renzo, L. D., & Marchetti, M. (2022) · Microbiology Research · doi:10.3390/microbiolres13020015 · Cited by 1
“As a consequence of this, there is the passage of bacterial material through the mucosa and the activation of a local and systemic chronic inflammatory mechanism, due to the translocation of bacterial fragments in the circulation, as indicated by the blood presence of bacterial DNA of intestinal species, highlighted b…”
BackgroundAnandh, U., & Saxena, A. (2023) · Journal of Renal Nutrition and Metabolism · doi:10.4103/jrnm.jrnm_6_23 · Cited by 1
He, H., Shen, M.-L., Sun, W., Tang, Y., Xu, X., & Xie, Y. (2019) · Europe PMC (PubMed Central) · Cited by 1
The intricate relationship between gut and kidney
da Cunha, R. S., & Stinghen, A. E. M. (2018) · Brazilian Journal of Nephrology · doi:10.1590/1678-4685-jbn-2018-00020001 · Cited by 1
Biliary Infection, Pancreatic Infection and Microecology
Jiang, J., Ren, Z., & Zheng, S. (2014) · Advanced topics in science and technology in China · doi:10.1007/978-3-662-43883-1_13
Review: Uremic Toxins and Gut Microbiome
Suzuki, T., & Abe, T. (2020) · Springer eBooks · doi:10.1007/978-981-15-7793-2_2
The Gut as a Source of Inflammation in Chronic Kidney Disease
Kamyar, L., & Nosratola, K.-Z. (2015)
Funt, R. (1981) · Digital Commons @ Butler University (Butler University)
Joshi, S., Tortorici, A. R., Sussman, E. J., & Kalantar‐Zadeh, K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818540-7.00054-9
Sherman, R. A. (2013) · Seminars in Dialysis · doi:10.1111/sdi.12089
“coli, Enterobacter, Pseudomonas) was detected in the blood of 6 of 30 nondialyzed ESRD patients (4).”
BackgroundDiet Strategies for the Patient with Chronic Kidney Disease
Ettinger, S. E. (2022) · Physician Assistant Clinics · doi:10.1016/j.cpha.2022.06.002
Characteristics of the gut microbiome in patients with Esophageal Squamous Cell CancerPreprint
Han, Z., Xu, H., Yu, S., Kang, M., & Chen, S. (2022) · Research Square · doi:10.21203/rs.3.rs-1935343/v1
Dysbiosis of Blood and Intestinal Microbiomes in Patients with Lung CancerPreprint
Zhang, X., Zhao, F., Chen, Y., Wang, L., Yang, W., Shan, J., & Wang, X. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4780212
Hu, X., Du, J., Xie, Y., Huang, Q., Xiao, Y., Chen, J., Yan, S., Gong, Z., & Ouyang, S. (2020) · Figshare · doi:10.6084/m9.figshare.11985015
BENEFÍCIOS DE PROBIÓTICOS NA DOENÇA RENAL CRÔNICA
da SILVA, J. F. B. (2024) · Intellectus Revista Acadêmica Digital · doi:10.21116/ri.v73i1.878
Kronik Böbrek Hastalıklarında Prebiyotik Kullanımının Hastalık Progresyonu Üzerine Etkileri
Yalçın, B., & Özkaya, Ş. Ö. (2024) · İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi · doi:10.38079/igusabder.1351434
Suandika, M., Handayani, R., & Muti, R. T. (2025) · BIO Web of Conferences · doi:10.1051/bioconf/202515201002
“Systemic inflammation has been proved to induce cellular change in microglia [7-10].”
Swift, O., Dasari, B. V. M., Finkelman, M., Zhang, Y., Sridharan, S., Vilar, E., & Farrington, K. (2025) · Hemodialysis International · doi:10.1111/hdi.70016
Metadata
- Authors
- WANG, F., JIANG, H., SHI, K., REN, Y., ZHANG, P., & CHENG, S.
- Affiliations
- First Affiliated Hospital of Xi'an Jiaotong University (CN)
- Xi'an Jiaotong University (CN)
- Corresponding author
- JIANG, HONGLI
- Venue
- Nephrology
- Publisher
- Wiley
- Published
- 2012-10-29
- Volume
- 17
- Issue
- 8
- Pages
- 733-738
- ISSN
- 1320-5358 (ISSN-L)
- 1440-1797
- OpenAlex
- W2140999961
- Cited by
- 209
- References
- 32
- Citations by year
- 2026: 8 · 2025: 4 · 2024: 17 · 2023: 18 · 2022: 19 · 2021: 22 · 2020: 24 · 2019: 23 · 2018: 16 · 2017: 13 · 2016: 17 · 2015: 14 · 2014: 9 · 2013: 4
- FWCI
- 6.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nephrology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China
- Topics
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Keywords
- gut bacterial translocation, end-stage renal disease, microinflammation, gut microbiota, D-lactate, intestinal permeability, C-reactive protein, interleukin-6, Klebsiella, Proteus, Escherichia, Enterobacter, Pseudomonas, dialysis patients
- MeSH terms
- Adult, Aged, Bacteria, C-Reactive Protein, Feces, Female, Humans, Inflammation, Kidney Failure, Chronic, Male, Middle Aged, RNA, Ribosomal, 16S, Biomarkers, Interleukin-6, Up-Regulation, Chi-Square Distribution, Case-Control Studies, Sequence Analysis, DNA, Inflammation Mediators, Bacterial Translocation, Lactic Acid, Ribotyping, Gastrointestinal Tract, Metagenome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
